Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wellesley Pharmaceuticals

Wellesley Pharmaceuticals
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series D LATEST DEAL TYPE (In Progress)
$15M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a drug designed to treat nocturia. The company's patented drug helps to treat the frequent need to urinate at night, enabling patients to sleep better at night without using the bathroom.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 3 Valley View Drive
  • Newtown, PA 18940
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Wellesley Pharmaceuticals’s full profile, request a free trial.

Wellesley Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 18-Apr-2016 $15M 000.00 0000 In Progress Clinical Trials - Phase 2
3. Later Stage VC (Series C) 01-Apr-2015 00.00 00.000 0000 Completed Clinical Trials - Phase 2
2. Angel (individual) 01-Oct-2014 $550K $1.05M 000.00 Completed Clinical Trials - Phase 2
1. Angel (individual) 11-Jun-2014 $500K $500K 000.00 Completed Clinical Trials - Phase 2
To view this company’s complete deal history including valuation and funding, request access »

Wellesley Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Axella Bioventures Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0

Wellesley Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
David Dill Founder, Chief Executive Officer, President & Board Member

Wellesley Pharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
Candan Karabagli Self Board Member 000 0000
Christopher Lineberry Self Board Member 000 0000
David Dill Wellesley Pharmaceuticals Founder, Chief Executive Officer, President & Board Member 000 0000
Michael Myers Ph.D Self Board Member 000 0000
Omer Karahan MD Self Board Member 000 0000